Showing 1 - 10 of 16
We examine six molecules facing initial loss of US exclusivity (LOE, from patent expiration or challenges) between June 2009 and May 2013 that were among the 50 most prescribed molecules in May 2013. We examine prices per day of therapy (from the perspective of average revenue received by retail...
Persistent link: https://www.econbiz.de/10013062618
Persistent link: https://www.econbiz.de/10010198694
Persistent link: https://www.econbiz.de/10003383050
Persistent link: https://www.econbiz.de/10003612984
Persistent link: https://www.econbiz.de/10011812699
The impact of stronger intellectual property rights in the software industry is controversial. One means by which patents can affect technical change, industry dynamics, and ultimately welfare, is through their role in stimulating or stifling entry by new ventures. Patents can block entry, or...
Persistent link: https://www.econbiz.de/10012751721
Persistent link: https://www.econbiz.de/10001143287
This paper explores Intel's strategy with respect to complements. We find that, as the literature predicts, Intel's entry decisions are shaped by the belief that it does not have the capabilities to enter all possible markets, and thus that it must encourage widespread entry despite the fact...
Persistent link: https://www.econbiz.de/10014053346
This paper draws on a detailed history of Intel's strategy with respect to the complementary markets for microprocessors to explore the usefulness of the current theoretical literature for explaining behavior. We find that as the literature predicts, Intel invests heavily in these markets, both...
Persistent link: https://www.econbiz.de/10013227066
Persistent link: https://www.econbiz.de/10003425699